Food Supplements | When do joint supplements become genuinely useful?

 

When Does a Joint Supplement Truly Become Beneficial?

 

Source: Wright, Anderson, Pye, and consensus articles published in Frontiers.


"My dog is still young, is it too early?"

"My dog is already old, is it still useful?"

There is no universal age at which a joint supplement automatically becomes relevant.

The benefit mainly depends on the dog's profile: its breed, weight, activity level, orthopedic history, actual age, muscle condition, and signs already observed daily.

Waiting for a clear lameness is not always the best strategy, especially for at-risk dogs. Conversely, supplementing a dog without particular risk factors too early is not a given.

 

 

What the Literature Suggests

Canine osteoarthritis is a progressive disease, often detected late.

Estimates vary depending on the populations studied, but several works show that it does not only affect very old dogs.

Wright et al. report that about 20% of dogs over one year old may already show signs consistent with osteoarthritis when structured screening is performed.

Anderson et al. also show that appendicular osteoarthritis can be identified in dogs of various ages, with a frequency that increases with age, weight, and certain risk factors.

This does not mean that all young dogs should be given a joint supplement.

It mainly means that mobility should not be monitored only when the dog gets old or starts to limp significantly.

 

 

Profiles where early introduction can be considered

High orthopedic risk breeds

In certain breeds, the risk of joint issues is higher.

This is notably the case for several large or heavy breeds, such as the Labrador, Golden Retriever, German Shepherd, Rottweiler, Bernese Mountain Dog, Newfoundland, or even some giant dogs.

In these profiles, discussing joint support after growth completion can be coherent, especially if other factors are added: intense activity, history of lameness, known dysplasia, overweight, or difficult recovery.

It must be clear: it is not about promising osteoarthritis prevention. It is rather about early support for a dog whose condition warrants particular vigilance.

 

Active, sport, or working dogs

A dog that runs a lot, jumps, brakes, frequently changes its footing, or works physically does not have the same constraints as a companion dog with moderate activity.

For these dogs, supplementation can be discussed as part of a strategy for locomotor support, recovery, and management of repeated mechanical stress.

The goal is not to guarantee that the dog will never develop osteoarthritis.

The goal is to integrate the supplement into a broader strategy: adapted activity, recovery, stable weight, veterinary follow-up, and regular observation of mobility.

 

Overweight dogs

Overweight remains one of the most important modifiable joint factors.

In this case, the priority is not to choose a supplement, but to reduce the mechanical stress on the joints.

A supplement may eventually have its place, but it will remain secondary as long as the weight is not managed.

For an overweight dog, the real priority is therefore to return to an appropriate weight, with the help of the veterinarian if necessary.

 

Dogs with orthopedic history

A dog that has previously had dysplasia, luxation, cruciate ligament rupture, orthopedic surgery, or repeated episodes of lameness is not in the same situation as a dog without a history.

In these contexts, supplementation can be discussed earlier, but it must be part of a supervised approach.

Diagnosis, pain, muscle mass, recovery, activity, and environment remain the main elements.

The supplement provides support. It does not replace the rest.

 

 

For a dog without particular risk factors

For a medium-sized dog, without overweight, without orthopedic history, without intense activity, and without signs of discomfort, very early supplementation is not necessarily justified.

Discussion often becomes more relevant in the second half of life, around 5 to 7 years old depending on the breed, size, lifestyle, and clinical examination.

This is not a strict rule.

A very active small dog, a large heavy dog, a sporty dog, or a dog that has already had locomotor episodes should not be approached in the same way.

 

 

Signs that should make you think

The question does not only depend on age.

Certain signs may warrant an earlier discussion:

  • stiffness upon rising;
  • difficulty getting started after rest;
  • hesitation on stairs;
  • slower recovery after exertion;
  • decreased desire to play;
  • intermittent lameness;
  • change in gait;
  • difficulty jumping into the car;
  • visible muscle loss;
  • irritability to touch or handling.

These signs do not all prove osteoarthritis, but they at least warrant serious observation and, if necessary, veterinary advice.

 

The right time is not the same for all dogs

A joint supplement is primarily meaningful when it responds to a specific context.

For a young dog without particular risk, the benefit is limited.

For an active, sporty, heavy, predisposed, overweight dog, or one with an orthopedic history, the discussion may become relevant earlier.

For a senior or already stiff dog, the objective changes again: it is no longer about early support, but about supporting mobility and joint comfort as part of a comprehensive management plan.

The most important thing is therefore not to reason solely by age.

You must reason by profile, constraints, observed signs, and risk level.

________________________________________________________________

Sources

  1. Wright A. et al. (2022). Identification of canine osteoarthritis using an owner-reported screening checklist and orthopaedic examination in general practice. Journal of Small Animal Practice. Reported prevalence around 20% of dogs over one year old.
  2. Anderson K.L. et al. (2018). Prevalence, duration and risk factors for appendicular osteoarthritis in a UK dog population under primary veterinary care. Scientific Reports. Osteoarthritis can start at any age but becomes more visible with age; risk factors include weight and age.
  3. Pye C. et al. (2024). Current evidence for non-pharmaceutical, non-surgical treatments of canine osteoarthritis. Journal of Small Animal Practice. Multimodal positioning and caution regarding preventive uses.
  4. Frontiers consensus / framework articles on canine osteoarthritis and its multimodal management.

 

0 comments

Leave a comment

Please note, comments need to be approved before they are published.